Molecular Partners AG

NASDAQ: MOLN · Real-Time Price · USD
3.47
-0.05 (-1.42%)
At close: Aug 15, 2025, 2:34 PM

Molecular Partners Income Statement

Financials in CHF. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
4.97M 7.04M 189.56M 9.33M
Cost of Revenue
n/a 47.84M 50.75M 55.72M
Gross Profit
-42.53M -40.81M 138.81M -46.39M
Operating Income
-61.22M -61.11M 116.61M -63.42M
Interest Income
3.38M 4.28M 1.2M 99K
Pretax Income
-54.04M -61.98M 117.85M -63.78M
Net Income
-54.04M -61.98M 117.85M -63.78M
Selling & General & Admin
17.16M 19M 21.82M 16.91M
Research & Development
48.6M 48.78M 50.75M 55.72M
Other Expenses
419K -47.48M 372K 125K
Operating Expenses
66.19M 20.3M 72.94M 72.75M
Interest Expense
25K 49K 648.12K 548K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
66.19M 68.15M 72.94M 72.75M
Income Tax Expense
2K n/a -717K 2K
Shares Outstanding (Basic)
34.03M 32.77M 32.47M 31.01M
Shares Outstanding (Diluted)
34.03M 32.77M 33.27M 31.01M
EPS (Basic)
-1.59 -1.89 3.63 -2.06
EPS (Diluted)
-1.59 -1.89 3.54 -2.06
EBITDA
-51.65M -59.52M 117.5M -60.66M
EBIT
-54.02M -61.95M 116.61M -63.23M
Depreciation & Amortization
2.37M 2.42M 2.39M 2.56M